Abstract
Once set, the inactive status of the X chromosome in female somatic cells is preserved throughout subsequent cell divisions. The inactive status of the X chromosome is characterized by many features, including late replication. In contrast to induced pluripotent stem cells (iPSCs) in mice, the X chromosome in human female iPSCs usually remains inactive after reprogramming of somatic cells to the pluripotent state, although recent studies point to the possibility of reactivation of the X chromosome. Here, we demonstrated that, during reprogramming, the inactive X chromosome switches from late to synchronous replication, with restoration of the transcription of previously silenced genes. This process is accompanied by accumulation of a new epigenetic mark or intermediate of the DNA demethylation pathway, 5-hydroxymethylcytosine (5hmC), on the activated X chromosome. Our results indicate that the active status of the X chromosome is better confirmed by early replication and the reappearance of 5hmC, rather than by appearance of histone marks of active chromatin, removal of histone marks of inactive chromatin, or an absence of XIST coating.
Similar content being viewed by others
Abbreviations
- 5hmC:
-
5-hydroxymethylcytosine
- 5mC:
-
5-methylcytosine
- EdU:
-
5-ethynyl-2′-deoxyuridine
- ESCs:
-
Embryonic stem cells
- iPSCs:
-
Induced pluripotent stem cells
- FISH:
-
Fluorescence in situ hybridization
- Xa:
-
Active X chromosome
- Xi:
-
Inactive X chromosome
References
Bacher CP, Guggiari M, Brors B, Augui S, Clerc P, Avner P, Heard E (2006) Transient colocalization of X-inactivation centres accompanies the initiation of X inactivation. Nat Cell Biol 8:293–299
Bailis JM, Forsburg SL (2003) It's all in the timing: linking S phase to chromatin structure and chromosome dynamics. Cell Cycle 2:303–306
Bogomazova AN, Lagarkova MA, Tskhovrebova LV, Shutova MV, Kiselev SL (2011) Error-prone nonhomologous end joining repair operates in human pluripotent stem cells during late G2. Aging 3:584–96
Bruck T, Benvenisty N (2011) Meta-analysis of the heterogeneity of X chromosome inactivation in human pluripotent stem cells. Stem Cell Research 6:187–193
Casas-Delucchi CS, Brero A, Rahn HP, Solovei I, Wutz A, Cremer T, Leonhardt H, Cardoso MC (2011) Histone acetylation controls the inactive X chromosome replication dynamics. Nat Commun 2:222
Chadwick BP, Willard HF (2004) Multiple spatially distinct types of facultative heterochromatin on the human inactive X chromosome. Proc Natl Acad Sci U S A 101:17450–17455
Chen J, Liu H, Liu J, Qi J, Wei B, Yang J, Liang H, Chen Y, Chen J, Wu Y, Guo L, Zhu J, Zhao X, Peng T, Zhang Y, Chen S, Li X, Li D, Wang T, Pei D (2012) H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs. Nat Genet 45:34–42
Chess A (2012) Mechanisms and consequences of widespread random monoallelic expression. Nat Rev Genet 13:421–428
Costa Y, Ding J, Theunissen TW, Faiola F, Hore TA, Shliaha PV, Fidalgo M, Saunders A, Lawrence M, Dietmann S, Das S, Levasseur DN, Li Z, Xu M, Reik W, Silva JC, Wang J (2013) NANOG-dependent function of TET1 and TET2 in establishment of pluripotency. Nature 495:370–374
Cowan CA, Klimanskaya I, McMahon J, Atienza J, Witmyer J, Zucker JP, Wang S, Morton CC, McMahon AP, Powers D, Melton DA (2004) Derivation of embryonic stem-cell lines from human blastocysts. N Engl J Med 350:1353–1356
Dawlaty MM, Breiling A, Le T, Raddatz G, Barrasa MI, Cheng AW, Gao Q, Powell BE, Li Z, Xu M, Faull KF, Lyko F, Jaenisch R (2013) Combined deficiency of Tet1 and Tet2 causes epigenetic abnormalities but is compatible with postnatal development. Dev Cell 24:310–23
Doege CA, Inoue K, Yamashita T, Rhee DB, Travis S, Fujita R, Guamieri P, Bhagat G, Vanti WB, Shih A, Levine RL, Nik S, Chen EI, Abelovich A (2012) Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2. Nature 488:652–655
Escamilla-Del-Arenal M, da Rocha ST, Heard E (2011) Evolutionary diversity and developmental regulation of X-chromosome inactivation. Hum Genet 130:307–327
Ficz G, Branco MR, Seisenberger S, Santos F, Krueger F, Hore TA, Marques CJ, Andrews S, Reik W (2011) Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation. Nature 473:398–402
Hiratani I, Ryba T, Itoh M, Rathjen J, Kulik M, Papp B, Fussner E, Bazett-Jones DP, Plath K, Dalton S, Rathjen PD (2010) Genome-wide dynamics of replication timing revealed by in vitro models of mouse embryogenesis. Genome research 20:155–69
Hysolli E, Jung YW, Tanaka Y, Kim KY, Park IH (2012) The lesser known story of X chromosome reactivation: a closer look into the reprogramming of the inactive X chromosome. Cell Cycle 11:229–35
International Stem Cell Initiative, Amps K, Andrews PW, Anyfantis G, Armstrong L, Avery S et al (2011) Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat Biotechnol 29:1132–1144
Ito S, D’Alessio AC, Taranova OV, Hong K, Sowers LC, Zhang Y (2010) Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature 466:1129–1133
Jeppesen P (2000) Immunofluorescence in cytogenetic analysis: method and applications. Gen Mol Biol 23:1107–1114
Keohane AM, O’neill LP, Belyaev ND, Lavender JS, Turner BM (1996) X-Inactivation and histone H4 acetylation in embryonic stem cells. Dev Biol 180:618–630
Kubiura M, Okano M, Kimura H, Kawamura F, Tada M (2012) Chromosome-wide regulation of euchromatin-specific 5mC to 5hmC conversion in mouse ES cells and female human somatic cells. Chromosome Res 20:837–48
Lagarkova MA, Eremeev AV, Svetlakov AV, Rubtsov NB, Kiselev SL (2010a) Human embryonic stem cell lines isolation, cultivation, and characterization. In Vitro Cell Dev Biol Anim 46:284–293
Lagarkova MA, Shutova MV, Bogomazova AN, Vassina EM, Glazov EA, Zhang P, Rizvanov AA, Chestkov IV, Kiselev SL (2010b) Induction of pluripotency in human endothelial cells resets epigenetic profile on genome scale. Cell cycle 9:937–946
Leeb M, Wutz A (2012) Establishment of epigenetic patterns in development. Chromosoma 121:251–262
Lund RJ, Närvä E, Lahesmaa R (2012) Genetic and epigenetic stability of human pluripotent stem cells. Nat Rev Genet 13:732–744
Marchetto MC, Carromeu C, Acab A, Yu D, Yeo GW, Mu Y, Chen G, Gage FH, Muotri AR (2010) A Model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 143:527–539
Mekhoubad S, Bock C, de Boer AS, Kiskinis E, Meissner A, Eggan K (2012) Erosion of dosage compensation impacts human iPSC disease modeling. Cell Stem Cell 10:595–609
Reik W (2007) Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 447:425–432
Sharp AJ, Stathaki E, Migliavacca E, Brahmachary M, Montgomery SB, Dupre Y, Antonarakis SE (2011) DNA methylation profiles of human active and inactive X chromosomes. Genome Res 21:1592–600
Silva J, Nichols J, Theunissen TW, Guo G, Van Oosten AL, Barrandon O, Wray J, Yamanaka S, Chambers I, Smith A (2009) Nanog is the gateway to the pluripotent ground state. Cell 138:722–737
Silva SS, Rowntree RK, Mekhoubad S, Lee JT (2008) X-chromosome inactivation and epigenetic fluidity in human embryonic stem cells. Proc Natl Acad Sci U S A 105:4820–4825
Soufi A, Donahue G, Zaret KS (2012) Facilitators and impediments of the pluripotency reprogramming factors’ initial engagement with the genome. Cell 151:994–1004
Stroud H, Feng S, Morey Kinney S, Pradhan S, Jacobsen SE (2011) 5-hydroxymethylcytosine is associated with enhancers and gene bodies in human embryonic stem cells. Genome Biol 12:R54
Szulwach KE, Li X, Li Y, Song CX, Han JW, Kim S, Namburi S, Hermetz K, Kim JJ, Rudd MK, Yoon YS, Ren B, He C, Jin P (2011) Integrating 5-hydroxymethylcytosine into the epigenomic landscape of human embryonic stem cells. PLoS genetics 7(6):e1002154
Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663–676
Tchieu J, Kuoy E, Chin MH, Trinh H, Patterson M, Sherman SP, Aimiuwu O, Lindgren A, Hakimian S, Zack JA (2010) Female human iPSCs retain an inactive X chromosome. Cell Stem Cell 7:329–342
Teichroeb JH, Betts DH, Vaziri H (2011) Suppression of the imprinted gene NNAT and X-chromosome gene activation in isogenic human iPS cells. PLoS One 6:e23436. doi:10.1371/journal.pone.0023436
Tomoda K, Takahashi K, Leung K, Okada A, Narita M, Yamada NA, Eilertson KE, Tsang P, Baba S, White MP, Sami S, Srivastava D, Conklin BR, Panning B, Yamanaka S (2012) Derivation conditions impact X-inactivation status in female human induced pluripotent stem cells. Cell Stem Cell 11:91–99
Willard HF, Latt SA (1976) Analysis of deoxyribonucleic acid replication in human X chromosomes by fluorescence microscopy. Am J Hum Genet 28:213–227
Wutz A (2011) Gene silencing in X-chromosome inactivation: advances in understanding facultative heterochromatin formation. Nat Rev Genet 12:542–553
Acknowledgments
This research was supported by RFBR (11-04-01212a) and Ministry of Science and Education (GK 14.512.11.0025).
Author information
Authors and Affiliations
Corresponding author
Additional information
Alexandra N. Bogomazova and Maria A. Lagarkova contributed equally to the publication.
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(PDF 848 kb)
Rights and permissions
About this article
Cite this article
Bogomazova, A.N., Lagarkova, M.A., Panova, A.V. et al. Reactivation of Х chromosome upon reprogramming leads to changes in the replication pattern and 5hmC accumulation. Chromosoma 123, 117–128 (2014). https://doi.org/10.1007/s00412-013-0433-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00412-013-0433-x